The multifaceted role of EMILIN2 in cancer University Students

dc.contributor.authorKhaled Ishtawi
dc.contributor.authorMohammed Ahmed
dc.contributor.authorSameh Sawalhi
dc.date.accessioned2021-08-31T07:29:54Z
dc.date.available2021-08-31T07:29:54Z
dc.date.issued2021-08-29
dc.description.abstractMalignant melanoma is a cancer originated from melanocytes of the skin and is one of the most aggressive types of skin cancer. Elastin microfibril interface-located proteins (EMILINs) are group of extracellular glycoproteins. One member, EMILIN 2 was suggested to play a role in activating cell death (apoptosis) through its ability to activate DR5 and DR4. In contrast, it also has been shown to bind to EGFR where it promotes tumor growth. We studied the role of EMILIN-2 for malignant melanoma (B16F10) growth. We used gene silencing and over expression to assess EMILIN2 and EGFR functions during melanoma growth. We found that increased levels of EMILIN-2 suppressed tumor proliferation in part through downregulation of EGFR expression and by activating DR5 and caspase-mediated apoptosis. The proteasome inhibitor bortezomib enhanced the expression of both EMILIN-2 and DR5. These data suggest that EMILIN2 overexpression can suppress tumor growth, and that certain anti-tumor drugs by upregulating EMILIN2 might enhance tumor apoptosis and suppression of tumor growth.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.11888/16073
dc.language.isoenen_US
dc.subjectmelanoma, B16F10, gene therapy, bortezomib, EMILIN 2, DR5, EGFR.en_US
dc.supervisorYousef Salamaen_US
dc.titleThe multifaceted role of EMILIN2 in cancer University Studentsen_US
dc.typeGraduation projecten_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
The multifaceted role of EMILIN2 in cancer University Students.pdf
Size:
22.83 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: